Introduction
In Drosophila, over 50 tumor suppressor genes have been identi®ed by genetic analyses (Watson et al., 1994) . The loss-of-function mutation of these genes results in hyperplasia or neoplastic overgrowth in various tissues, leading to the death of these insects (Gate et al., 1989) . Several genes which encode for polypeptides homologous to the Drosophila tumor suppressor genes have been identi®ed in mammalian cells, and they have been recently shown to be involved in various cellular events including growth regulation and dierentiation (Makino et al., 1997; Nakamura et al., 1998) .
The Drosophila lethal(3)malignant brain tumor (Dl(3)mbt) gene is reported to be one of the tumor suppressor genes of Drosophila melanogaster, and its recessive mutations are associated with malignant transformation of the neuroblasts and ganglion-mother cells in the presumptive adult optic centers in the larval brain (Gate et al., 1993; Wismar et al., 1995) . The predicted amino acid sequences of D-l(3)mbt protein reveal that it contains three distinct domains: a C2/C2 type zinc ®nger domain, three repeat units called`mbt repeats' each about 100 amino acids in length, and a Cterminal a-helical segment comprised of an approximately 60-amino acid motif termed the SPM (Scm, ph, mbt) domain (Bornemann et al., 1996; Wismar et al., 1995) . However, any characteristics of the D-l(3)mbt protein such as tissue distribution, subcellular localization, functions of the mbt repeats and the SPM domain, have not yet been identi®ed. Therefore, the biochemical role of the D-l(3)mbt protein in the suppression of tumorigenesis is not known.
The D-l(3)mbt protein is similar to a protein encoded by the sex comb on midleg (Scm) gene in Drosophila (Bornemann et al., 1996) . The Scm gene, which encodes a protein with three zinc ®nger domains, two`mbt repeats' and an SPM domain, has been identi®ed as a member of the Polycomb group (PcG) of genes. The PcG proteins are classi®ed together based on their common role in the stable transcriptional repression of homeotic genes during Drosophila embryogenesis (Pirrotta, 1997a,b; Simon, 1995) . More than 15 genes have been identi®ed to date as members of the PcG gene family by their segmental transformation phenotypes which are caused by the ectopic expression of multiple homeotic genes, but individual PcG proteins are diverse in sequence and structure (Pirrotta, 1997a,b; Simon, 1995; van Lohuizen, 1998; Yamamoto et al., 1997) . These PcG proteins have been found to interact with one another to form chromatin components that are colocalized at the same sites in polytene chromosomes in Drosophila and to inactivate their target genes. The extensive homology between Dl(3)mbt and Scm raises the possibility that they are functionally related (Bornemann et al., 1996) .
In this study, we isolated the ®rst human homolog of the D-l(3)mbt gene, which we designated h-l(3)mbt, by a combination of a computer analysis of the expressed sequenced tag (EST) databases and a twostep polymerase chain reaction (PCR) procedure (Makino et al., 1997; Nakamura et al., 1998) . We report here the chromosome location of this gene and its mRNA expression in various human tissues and cancer cells. We also report that the h-l(3)mbt protein shows a speckled distribution in interphase nuclei and completely overlaps with condensed chromosomes in mitotic cells, but it is not colocalized with one of the mammalian homologs of PcG proteins, Bmi1 (Alkema et al., 1997a,b) . These ®ndings suggest that the h-l(3)mbt is structurally similar to a member of PcG chromatin-binding complex but is not involved in the previously identi®ed PcG complex. Furthermore, we expressed the h-l(3)mbt gene in the human glioma cell line U251MG with the use of an adenovirus-mediated gene activation system (Kanegae et al., 1995 (Kanegae et al., , 1996 , and we found that overexpression of h-l(3)mbt aects nuclear segregation and cytokinesis, resulting in the formation of multinucleated cells. The h-l(3)mbt is potentially involved in regulation of cell cycle progression by participating in the formation of a DNA-binding protein complex.
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Results

Identi®cation of the novel human homolog of the Drosophila l(3)mbt gene
In an eort to isolate a human homolog of the Drosophila l(3)mbt (D-l(3)mbt) gene, we focused on sequence database searching using the Blast algorithm. A tblastn search of the Genbank TM database using the D-l(3)mbt peptide sequences revealed that an EST clone with the accession number H23073 has sequence similarity. The sequence of the H23073 EST clone was not found to be identical to any previously reported gene. Based on the sequence of this EST, we performed a two-step PCR to clone the full-length cDNA. We identi®ed a 3, 394 bp cDNA which contains a single large open reading frame (ORF) encoding a polypeptide of 772 amino acids (Figure 1a ). This ORF is preceded by a 252 bp 5'-translated region containing seven AUG codons, none of which gave rise to a signi®cantly large ORF. In the course of the cDNA cloning, we identi®ed an alternative splicing isoform which has an additional 118-bp insertion at the Cterminal portion of the ORF. This insertion is predicted to generate a shorter type (738 amino acids) of l(3)mbt proteins ( Figure 1a ). The splicing isoforms encoding 772 amino acids and 738 amino acids were termed h-l(3)mbt-I and h-l(3)mbt-II, respectively. A tblastn search of the non-redundant nucleotide database revealed that the predicted amino acid sequences of the cloned cDNA have high similarity to proteins encoded by D-l(3)mbt gene (Accession no. X80839, smallest sum probability P(n)=2e-81) and Drosophila Scm gene (Accession no. U49793, P(n)=3e-41). The overall amino acid sequences of the h-l(3)mbt-I and h-l(3)mbt-II proteins have 29.4% identity and 30.6% identity with D-l(3)mbt protein, respectively ( Figure 1a ). The domain organization characteristic of the D-l(3)mbt was also conserved in the h-l(3)mbt polypeptide, with three mbt-repeats in the central portion of the protein, a C2HC zinc ®nger motif, and an anterior part of the SPM domain ( Figure  1b ). However, a lysine-rich region and a C2/C2 zinc ®nger domain in the N-terminal region presented in Dl(3)mbt were not conserved in the h-l(3) mbt. The three mbt-repeats have 46% identity to the analogous domain of D-l(3)mbt. A PSORT analysis predicted that l(3)mbt has three putative nuclear localization signals (NLSs) at the amino acid positions of 148 ± 153, 608 ± 626 and 622 ± 628. To identify the chromosomal localization of the h-l(3)mbt gene, we performed PCR mapping using a 
Expression of h-l(3)mbt mRNA in human tissues and cancer cell lines
To determine the expression pattern of h-l(3)mbt mRNA, we performed a Northern blot analysis on various human tissues by using h-l(3)mbt riboprobe. A 4.7 kb h-l(3)mbt transcript was widely expressed among the normal adult tissues ( Figure 2a ) and some cancer cell lines (Figure 2b ). Among the cancer cell lines examined, the 4.7 kb transcript was markedly reduced in the colorectal cancer cell line SW480 and the promyelocytic leukemia cell line HL-60.
To determine which h-l(3)mbt splicing isoform (type I or II) is expressed in normal cells, we performed an RT ± PCR analysis of peripheral blood lymphocytes (PBLs) from twenty normal volunteers using a set of primers, S2 and HCT, which are capable of amplifying both type I and type II transcripts. As shown in Figure 2c , all normal PBL samples expressed both isoforms, and the expression patterns of type I and type II transcripts varied depending on the samples.
Detection of the h-l(3)mbt protein
To examine the expression and subcellular localization of the h-l(3)mbt proteins, we raised rat polyconal antiserum against the GST-h-l(3)mbt-I fusion proteins. First, a Western blot analysis of VA13 cells, which were transiently transfected by the Myc-tagged h-l(3)mbt-I expression plasmid (pBJ-Myc-h-l(3)mbt-I) or Myc-tagged h-l(3)mbt-II expression plasmid (pBJMyc-h-l(3)mbt-II), and U2OS osteosarcoma cells, which are known to express high levels of PcG proteins (Alkema et al., 1997a,b) , was performed using the anti-h-l (3) By using the anti-h-l(3)mbt antibody, we performed a Western blot analysis to detect the endogenous h-l(3)mbt proteins in several human cell lines. The 100 kDa protein was clearly detected in lysates from U2OS cells, T98MG astrocytoma cells and 293 cells transformed with adenovirus E1, and weakly positive in RBR17T astrocytoma cells, but not detected in VA13 lung ®broblasts transformed with SV40 T antigen and various cell lines (U251MG, ASPC1, Hela, HT1080 and SW480) (Figure 3b ).
Subcellular localization of h-l(3)mbt protein
To examine the subcellular localization of h-l(3mbt proteins, we performed an immunocytochemical analysis of U2OS cells, in which the expression of endogenous h-l(3)mbt protein was detected by Western blot analysis. In interphase cells, speci®c staining was weakly found in the nucleus with no staining in the cytoplasm (Figure 4a ). The h-l(3)mbt protein was excluded from the nucleolus and showed a speckled and scattered distribution throughout the nucleoplasm. In mitotic cells, intense staining by the anti-h-l(3)mbt antibody was observed at condensed chromosomes from the prophase to telophase (Figure 4a ± c). The h-l(3)mbt staining was constantly observed with condensed DNA in the merged image with propidium iodide (PI) staining. Since h-l(3)mbt protein level determined by Western blot analysis was not changed throughout the cell cycle (data not shown), the increased intensity of h-l(3)mbt staining at mitotic phase re¯ects the chromatin organization.
The subnuclear localization of the h-l(3)mbt protein in interphase nuclei is reminiscent of the speckled distribution of the PcG proteins. To determine whether h-l(3)mbt protein colocalizes with PcG proteins, we performed a double-labeling experiment with antih-l(3)mbt antibody and the monoclonal antibody F6 (Alkema et al., 1997a,b) against Bmi1 protein, which is one of the human PcG proteins and which was shown to be present in a largely overlapping pattern with other PcG proteins. Although both the h-l(3)mbt and The distribution of endogenous h-l(3)mbt protein was observed at dierent cell cycle stages; (a) cells at interphase (arrows) and prophase (arrowhead), (b) a cell at metaphase, and (c) a cell at telophase. The ®xed cells were incubated with anti-h-l(3)mbt antibody followed by FITC-conjugated secondary antibody (green¯uorescence) and propidium iodide (PI, red¯uorescence) for staining of the DNA. Digital images were captured from two dierent channels, and each panel shows the FITC channel on the left, the PI channel in the center and the merged image on the right. (d and e) The distribution of the h-l(3)mbt protein was compared with that of the Bmi1 protein in a cell at interphase (d) and a cell at metaphase (arrows in e). The green¯uorescence (left panels) and the red¯uorescence (center panels) indicate h-l(3)mbt and Bmi1 proteins, respectively. The merged images are shown in the right panels Bmi1 proteins showed a speckled distribution, they did not colocalize in interphase nuclei (Figure 4d) . Additionally, Bmi1 staining was not seen in mitotic cells, as in a previous study (Alkema et al., 1997a,b) , in contrast to the intense h-l(3)mbt staining at condensed chromosomes in mitotic cells (Figure 4e ). These ®ndings suggest that the h-l(3)mbt is a member of a DNA binding protein complex which is similar to PcG nuclear domains but is functionally distinct from previously identi®ed PcG proteins. The U251/h-l(3)mbt-I and -II cells were infected with (+) or without (7) AxCANCre for 12 h and the medium was then changed to adenovirus-free growth medium. At 48 h after the medium change, the cells were ®xed and stained with anti-h-l(3)mbt antibody and PI. Then, multinucleated cells that had more than four nuclei were counted. Each bar presents the average values from three independent determinations; values from each independent determination varied by less than 10%
Overexpression of h-l(3)mbt induces multinucleated cells
The Drosophila l(3)mbt gene is known to be required for the negative control of cell proliferation. Furthermore, our immuno¯uorescence ®ndings suggest that the h-l(3)mbt protein is tightly associated with condensed chromosomes in mitotic cells. These ®ndings prompted us to examine the involvement of h-l(3)mbt in cell cycle regulation. To investigate the role of h-l(3)mbt in proliferating cells, we employed the inducible overexpression of h-l(3)mbt gene in U251MG cells by using the Cre-mediated gene activation system (Kanegae et al., 1995 (Kanegae et al., , 1996 . The U251MG cells, in which endogenous h-l(3)mbt proteins has not been detected, were transfected with pCALNL5, pCALNL5/h-l(3)mbt-I, or pCALNL5/ h-l(3)mbt-II, and clones were selected with G418. Cells carrying vector alone (U251/mock), pCALNL5/ h-l(3)mbt-I (U251/h-l(3)mbt-I) or pCALNL5/ h-l(3)mbt-II (U251/h-l(3)mbt-II) were grown in the presence or absence of the Cre recombinase producing recombinant adenovirus (AxCANCre) for 12 h, and the medium was then changed to adenovirus-free growing medium. A Western blot analysis revealed that the expression of h-l(3)mbt-I and h-l(3)mbt-II proteins was induced in the U251/h-l(3)mbt-I and U251/h-l(3)mbt-II cells, respectively, at 48 h after the medium change (Figure 5a ). When h-l(3)mbt-I and hl(3)mbt-II were induced for more than 48 h, a signi®cantly higher prevalence of cells failed to complete normal mitosis and became multinucleated (Figure 5b ). In contrast, AxCANCre-treated U251/ mock cells completed mitosis and exhibited normal nuclear morphologies. When overexpression of hl(3)mbt type I and type II proteins was induced, 30.1+2.5% (mean+s.d.) and 23.0+4.2% of the cells became multinucleated, respectively, and they had more than four nuclei. In contrast, the proportions of the multinucleated cells in the absence of the adenovirus treatment were 1.7+0.4% (type I) and 1.7+0.8% (type II). Results from these assays con®rmed that overexpression of h-l(3)mbt signi®cantly induced multinucleated cells (Figure 5c ). These results suggest that the expression of h-l(3)mbt protein at a proper level and/or timing is required to accomplish normal mitosis.
Discussion
In this study we have identi®ed and characterized the ®rst human homolog of the Drosophila l(3)mbt tumor suppressor, designated h-l(3)mbt. The h-l(3)mbt protein as well as the D-l(3)mbt has signi®cant homology to a protein encoded by the Drosophila Scm gene, which is a member of the PcG gene family (Bornemann et al., 1996) . PcG proteins form chromatin complexes that can silence gene expression and are considered to be responsible for maintaining the repression of homeotic genes through many cell divisions in Drosophila embryogenesis (Pirrotta, 1997a,b; Simon, 1995; van Lohuizen, 1998 ). Therefore, animals mutant for any of the PcG genes show multiple homeotic transformations resulting from the ectopic expression of homeogenes. Several mammalian homologs of PcG members have recently been identi®ed and shown to be involved in the maintenance of Hox gene expression boundaries throughout development. Bmi1 and Mel18 proteins share sequence similarity to the Drosophila Posterior sex combs (Psc) and its relative Su(z)2, which are members of the family of PcG proteins. Mice lacking the Bmi1 gene or the Mel18 gene show a posterior transformation of the axial skeleton which correlates with an anterior shift of several Hox gene expression boundaries, similar to the Drosophila PcG loss-offunction mutants (Akasaka et al., 1996; van der Lugt et al., 1996) . The murine M33 protein, which shares homology with the Drosophila Polycomb (Pc) protein, was shown to rescue in part the Pc mutant phenotype in transgenic¯ies (Muller, 1995) . Furthermore, Bmi1 has been found to interact with MPc2, a murine homolog of Pc protein, and Mph1/Rae28, which shares homology with the Drosophila polyhomeotic (ph) protein (Alkema et al., 1997b) . It has also been shown that all these proteins including Bmi1, Mel18, Mph1/Rae28, M33 and MPc2 compose multimeric protein complexes which are detected as subnuclear speckles in interphase nuclei (Alkema et al., 1997a,b) . These ®ndings indicate that the PcG complexes exist not only in Drosophila cells but in mammalian cells. In this study, we found that h-l(3)mbt protein is present at condensed chromatin and shows a speckled and scattered distribution in interphase nuclei, which is similar to the distribution of PcG proteins. However, our double-labeling experiment with anti-hl(3)mbt antibody and the anti-Bmi1 antibody showed that h-l(3)mbt protein does not colocalize with Bmi1 protein. In addition, h-l(3)mbt protein associates strongly with the condensed chromosome during mitosis, whereas PcG proteins including Bmi1 are known to dissociate from metaphase chromosomes and disperse into the cytoplasm (Buchenau et al., 1998) . These lines of evidence suggest that h-l(3)mbt protein is not a member of the family of previously identi®ed PcG proteins and potentially compose another chromatin-binding protein complex.
Recent genetic studies have demonstrated that several PcG-like chromatin binding factors identi®ed in Drosophila are essential not only for gene silencing but also for the structural changes of the chromosome during mitosis. For example, HP1 (heterochromatin protein 1), which carries a motif called chromo-domain that is also present in Pc protein, is a structural component of heterochromatin and is necessary for chromosome condensation and segregation (Kellum et al., 1995; Pak et al., 1997) . CCF (centrosomal and chromosomal factor), which shares homology to the chromatin-binding sites of the Psc protein, is required for the proper condensation of mitotic chromosomes (Kodjabachian et al., 1998) . Enhancer of zeste, which was identi®ed as a component of dierent PcG-like chromatin-binding complex, is required to maintain chromosome integrity during mitosis (Gatti et al., 1989; Jones et al., 1998; Sewalt et al., 1998; van Lohuizen et al., 1998) . These ®ndings allow us to speculate that h-l(3)mbt, which shares homology with the functional domains of some PcG proteins, may take part in the proper condensation of mitotic chromosomes.
Mitosis has seven sequential steps including chromosome condensation, breaking down of the h-l(3)mbt associates with mitotic chromosomes H Koga et al nuclear envelope, congression (the condensed chromosomes align on the center of the spindle), segregation (the daughter chromosomes then move to opposite poles of the spindle), chromosome decondensation, nuclei reformation and cytokinesis. These events are strictly regulated by sequential molecular interactions, and the misregulation of the mitotic process is considered to cause abnormal nuclei, miseggragated chromosomes and aneuploidy which are a hallmark of cancer cells. Therefore, it is plausible that proteins involved in chromosome condensation and maintaining the integrity of chromosome segregation may play a role in suppression of cellular transformation. We have shown that endogenous h-l(3)mbt protein associates with condensed chromosomes throughout the mitotic phase. Furthermore, overexpression of h-l(3)mbt protein in U251MG cells by using a Cre-mediated gene activation system leads to failures of proper chromosome segregation and cytokinesis, which result in generation of multinuclei. The molecular basis of mitotic events is being studied extensively and it was clari®ed that multinucleated cells are a common phenotype which is produced by the functional disruption of mitosis-associated molecules. AIM-1, which is a mammalian protein kinase homologous to Drosophila Aurore and Saccharomyces cerevisiae Ipl1, is required for chromosome segregation, and overexpression of the kinase-inactive AIM-1 disrupts cleavage furrow formation and cytokinesis, resulting in the induction of multinucleated cells (Terada et al., 1998) . TXBP181, which is a human homolog of yeast mitotic checkpoint MAD1 protein, binds to HsMAD2 and localizes to the centrosome during metaphase. The transient transfection with a TXBP181 mutant incapable of binding to HsMAD2 induces multinucleated cells (Jin et al., 1998) . The molecular mechanism that the overexpressed h-l(3)mbt induces the multinucleated cells is still obscure. But, one interpretation of our observations is that chromosome condensation and segregation is directly regulated by h-l(3)mbt protein expressed at a strict timing and a proper level and, thereby, both overexpression and down-regulation of h-l(3)mbt protein may induce premature mitosis. Our findings, together with the evidence that the loss-offunction mutation of D-l(3)mbt causes hyperplasia and transformation of the neural cells in Drosophila (Gate et al., 1993; Wismar et al., 1995) , leads hypotheses that h-l(3)mbt is an element required for proper progression of mitosis, and that misregulation of h-l(3)mbt function may be a causal role in cellular transformation due to loss of chromosomal integrity.
The h-l(3)mbt gene has been mapped on the chromosome 20q12; however, major genetic alterations including large deletions and translocations of this region have not been reported in any cancer. On the other hand, the ampli®cation of 20q11-13 is common in breast cancer and correlates with poor prognosis, indicating the presence of some oncogenes at this locus Tanner et al., 1996) . To determine involvement of the h-l(3)mbt gene in development of human cancers, further experiments for investigating alterations, including deletion, ampli®cation and mutation, of the hl(3)mbt gene in various inherited and sporadic cancers are required.
Materials and methods
EST database screening and PCR-based full-length cDNA cloning
We searched for human homologs of the l(3)mbt gene by scanning a database of the expressed sequence tag (dbEST) at the National Center for Biotechnology Information (NCBI) using tblastn (Adams et al., 1991; Altschul et al., 1990) . The sequence information of the EST clone H23073 allowed the synthesis of four speci®c primers; 5'UP-1 (5'-TAGCCACA-TACCTCAGCCACG-3'), 5'UP-2 (5'-CCATCAAAGTGCA-GGCGTAGG-3', 3'-DW1 (5'-AAGCACCTGTTTGTGAG-CCAG-3'), and 3'-DW2 (5'-AAGCTGTTTGACCGCATGA-AC-3'). The PCR-based full-length cDNA cloning was performed by using a fetal brain Marathon-Ready cDNA TM (Clontech) according to the manufacturer's instructions. For ampli®cation of the 5' region, the ®rst PCR was performed using the 5'UP-2 and AP1 (an adaptor primer for the cDNA, 5'-CCATCCTAATACGACTCACTATAGGGC-3') primers and the fetal brain Marathon-Ready cDNA TM in a 25 ml reaction volume for 35 cycles. The ®rst PCR product was used as a template in the second run, where AP2 (another adaptor primer for the cDNA, 5'-ACTCACTATAGGGCTC-GAGCGGC-3') and 5'UP-1 were utilized as primers to amplify the 5' region cDNA. For ampli®cations of the 3' region, the 3'DW1 and AP1 primers were used for the ®rst PCR, and AP2 and 3'DW2 were used for the second PCR. The PCR fragments were ligated into a pCRII TA cloning vector and sequenced. All PCR procedures were performed by using rTth DNA polymerase (Perkin Elmer), which has proof-reading activity. The nucleotide sequence was con®rmed by sequencing several clones (at least ®ve) to avoid errors introduced during the PCR reaction. The DNA and protein sequences were compared by the basic local alignment search tool (BLAST) network service at NCBI.
PCR mapping of h-l(3)mbt gene and FISH analysis
Radiation hybrid (RH) mapping of h-l(3)mbt gene was performed as previously described (Makino et al., 1997 ) using a set of primers (RH-1 : 5'-TCATTTGCTTGCCAAACT-TAG-3' and RH-2 : 5'-GTTAGGATCCTTGCAGTAAAT-CAC-3') which were designed based on a partial genomic sequence of the h-l(3)mbt gene. The RH-1 and RH-2 primers were expected to amplify a 138 bp PCR product from human genomic DNA as a template. The PCR results of the Radiation Hybrid Panel were sent to the Whitehead Institute/MIT Center for Genome Research via the WWW (http://www-genome.wi.mit.edu/) for the mapping of the genes relative to the radiation hybrid map of the human genome (Hudson et al., 1995) . FISH analysis was performed by using the method previously described (Makino et al., 1997) .
Northern blot analysis
Northern blots derived from multiple human tissues and cancer cell lines containing 2 mg of poly(A) + RNA per lane were obtained from Clontech. The membranes were probed with a 1.8 kb h-l(3)mbt RNA fragment synthesized in vitro using T7 polymerase and [a-32 P]UTP. A 2.0 kb human b-actin cDNA fragment that had been labeled with a-32 P-dCTP by random-primed labeling was used as a control probe. The membranes were exposed to X-ray ®lm with an intensifying screen for 3 days at 7708C.
Reverse transcription-polymerase chain reaction (RT ± PCR)
Total RNA was extracted from peripheral blood lymphocytes (PBLs) of normal volunteers. cDNA synthesis was performed using 5 mg of total RNA incubated in a 20 ml volume reaction containing 50 mM Tris-HCl (pH 8.3), 10 mM DTT, 10 mM KCl, 0.5 mM dNTP, 30 mg RNAsin (GIBCO ± BRL) and 150 mg superscript II reverse transcriptase (GIBCO ± BRL) for 1 h at 428C. The RT ± PCR to evaluate the alternative splicing of h-l(3)mbt transcript was carried out by using S2 (5'-AAGGAAGAAGCCTCGCCATCA-3') and HCT (5'-TTAAAACCATGGTCCCATAAG-3') primers. The PCR was performed for 40 cycles which consisted of denaturation at 958C for 30 s, annealing at 628C for 30 s, and extension at 728C for 45 s. The ampli®ed products were electrophoresed in 2% agarose gels and visualized by ethidium bromide staining and UV transillumination.
Expression of GST fusion protein and production of anti-h-l(3)mbt polyclonal antibody
The full-length ORF of the h-l(3)mbt-I cDNA was ampli®ed by PCR from the lZAP human fetal brain cDNA library using the primer GST ± S1 (5'-CGTGAGGATCCAT-GAGGCGAAGAGAGGCCCATG-3') and the primer RH-2 (5'-GTTAGGATCCTTGCAGTAAATCAC-3'), each containing BamHI site (underlined). The PCR fragment was subcloned into a pGEX-2TH bacterial expression vector. The expression and puri®cation of the GST-h-l(3)mbt-I fusion protein were performed as described previously (Takeshima et al., 1994) . Antibody against h-l(3)mbt-I was raised by the subcutaneous immunization of rats with the GST-h-l(3)mbt-I fusion protein mixed with GERBU adjuvant 10 (GERUB Biotechnik) on a biweekly injection schedule. The animals were sacri®ced, and sera were collected 10 days after the last boost. The antiserum was precleared with excess GSTconjugated GSH-beads and stored in aliquots at 7208C.
Construction of the h-l(3)mbt expression plasmid
Myc epitope-tagged h-l(3)mbt-I and -II expression plasmids were constructed by ligation of the XbaI/BamHI-digested fragments containing the full-length ORF of the h-l(3)mbt-I and -II cDNA into the expression vector pBJ-Myc. These constructs were named pBJ-Myc-h-l(3)mbt-I and -II. To express Myc-tagged h-l(3)mbt-I and -II, pBJ-Myc-h-l(3)mbt-I and -II plasmids were transfected into VA13 cells by the liposome-mediated gene transfer method (Felgner et al., 1987) .
Western blot analysis
Samples containing equal amounts of cell lysates extracted from equal numbers of cells were resolved by 8% sodium dodecyle sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE). After being blotted on a nitrocellulose ®lter, the ®lters were probed with the anit-Myc monoclonal antibody, the anti-h-l(3)mbt antiserum or anti-b-tubulin antibody (Chemicon) by using the method previously described (Makino et al., 1997) .
Immuno¯uorescence procedure and confocal laser scanning microscopic analysis (CLSM) Cells were seeded on glass-bottom culture dishes (MatTek Corp.) and incubated at 378C, then washed twice with phosphate-buered saline (PBS) and ®xed in 4% paraformaldehyde (PFA) for 10 min followed by 0.2% Triton X-100 for 5 min. After being washed with PBS, the cells were incubated with diluted anti-l(3)mbt antiserum (1 : 100) in PBS containing 0.3% bovine serum albumin (BSA) for 60 min at room temperature. After being washed with PBS, the cells were incubated with diluted FITC-conjugated secondary antibody ((1 : 200) (Biosource) for 60 min). For the ®nal 5 min, propidium iodide (Sigma) was added to make a ®nal concentration of 1 mg/ml for nuclear staining. For the examination of the colocalization of h-l(3)mbt and Bmi1 proteins, cells were double-stained with anti-h-l(3)mbt antiserum and the anti-Bmi1 monoclonal antibody F6 (Alkema et al., 1997a,b) followed by FITC-conjugated antirat Ig antibody and Cy3-conjugated anti-mouse Ig antibody (Biological Detection Systems, Inc.). After being washed with PBS, the cells were mounted in 50% glycerol, and visualized with a confocal microscope (Fluoview, Olympus) equipped with an argon gas laser and appropriate ®lter sets to allow the simultaneous recording of¯uorescein. Fluorescence micrographs were recorded using PL APO 606 or 406 objectives and sampled with 102461024 pixels and 8-bit resolution per color.
Inducible expression of the h-l(3)mbt in mammalian cells
The constructs corresponding to Cre-mediated h-l(3)mbt-I and h-l(3)mbt-II expression plasmids were generated by ligating the EcoRI/BamHI fragments containing the fulllength ORF of the h-l(3)mbt-I and h-l(3)mbt-II cDNA into the pCALNL5 plasmid which has a Cre-mediated activation unit (Kanegae et al., 1995 (Kanegae et al., , 1996 . These constructs were named pCALNL5/h-l(3)mbt-I and pCALNL5/h-l(3)mbt-II. The plasmids (pCALNL5, pCALNL5/h-l(3)mbt-I and pCALNL5/h-l(3)mbt-II) were microinjected into the nucleus of U251MG cells with a Micromanipulator 5171 (Eppendorf). Clones were selected in medium containing 400 mg/ml geneticin (GIBCO BRL). The drug-resistant cell lines were infected with AxCANCre adenovirus which produces Cre recombinase (Kanegae et al., 1996) for 12 h in DMEM/F12 culture medium, and then the medium was changed to adenovirus-free growing medium. More than 48 h after the infection, cells were prepared for Western blot and CLSM analyses as described above. For a quantitation of the multinucleated cells, pre-and post-induced cells were stained with anti-h-l(3)mbt antibody and PI, then about 200 cells were counted.
